- Home
- AAL vs CORT Comparison
AAL vs CORT Comparison
Compare AAL & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AAL | CORT |
|---|---|---|
| Founded | 1930 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 7.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AAL | CORT |
|---|---|---|
| Price | $15.58 | $81.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 6 |
| Target Price | $15.21 | ★ $130.20 |
| AVG Volume (30 Days) | ★ 59.6M | 852.0K |
| Earning Date | 01-22-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 115.68 | N/A |
| EPS | ★ 0.90 | 0.87 |
| Revenue | ★ $54,294,000,000.00 | $741,172,000.00 |
| Revenue This Year | $2.20 | $23.79 |
| Revenue Next Year | $6.29 | $40.97 |
| P/E Ratio | ★ $17.16 | $94.20 |
| Revenue Growth | 1.27 | ★ 17.92 |
| 52 Week Low | $8.50 | $49.00 |
| 52 Week High | $19.10 | $117.33 |
Technical Indicators
Market Signals| Indicator | AAL | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 66.81 | 51.07 |
| Support Level | $14.87 | $78.07 |
| Resistance Level | $16.08 | $89.00 |
| Average True Range (ATR) | 0.51 | 3.47 |
| MACD | 0.08 | -0.31 |
| Stochastic Oscillator | 80.36 | 37.54 |
Price Performance
Historical ComparisonAbout AAL American Airlines Group Inc.
American Airlines is the world's largest airline by aircraft, capacity, and scheduled revenue passenger miles. Its major US hubs are Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C. It generates over 30% of US airline revenue connecting Latin America with destinations in the United States. After completing a major fleet renewal, the company has the youngest fleet of US legacy carriers.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.